← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Everolimus currently has availability issues reported in 3 European registers: Germany, Italy, Sweden.
Shortage ATC L01EG02 · also listed as: EVEROLIMUS · data refreshed 11 September 2026
As of 11 September 2026, 3 of the 9 tracked registers list current availability issues for Everolimus, covering 5 affected product presentations. The longest-running open report was filed in Italy on 2025-09-20 and has now been open for about 12 months. Where agencies state a cause, unexpectedly high demand lead with 2 of the 3 stated-cause reports, followed by commercial decisions or discontinuation with 1. The furthest expected-resolution date currently on file is 2026-11-30; the earliest is 2026-09-17. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Italy reported first (2025-09-20), with Sweden following roughly 6 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Everolimus is coded L01EG02 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Resolved Everolimus HCS 2,5 mg Tabletten + 1 more productsEverolimus HCS 5 mg Tabletten | 2026-06-17 | — | — | register ↗ |
| 🇩🇪 Germany | Shortage Everolimus-ratiopharm 2,5 mg Tabletten | 2025-12-01 | 2026-10-01 | Erhöhte Nachfrage Alternatives: N/A | register ↗ |
| 🇮🇹 Italy | Shortage EVEROLIMUS MEDAC + 1 more productsEVEROLIMUS SANDOZ GMBH | 2025-09-20 | 2026-08-17 | Elevata richiesta: distribuzione contingentata Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
| 🇸🇪 Sweden | Shortage Everolimus Avansor 5 mg Tablett + 2 more productsEverolimus Krka 2,5 mg Tablett Everolimus Viatris 2,5 mg Tablett | 2026-03-19 | 2026-11-30 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Everolimus in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | EVEROLIMUS SANDOZ GMBH | Shortage | 2026-10-01 | — | Cessata commercializzazione definitiva |
| 🇸🇪 SE | Everolimus Viatris 2,5 mg Tablett | Discontinued | 2026-09-30 | — | |
| 🇦🇹 AT | Everolimus HCS 2,5 mg Tabletten | Resolved | 2026-07-23 | — | |
| 🇸🇪 SE | Everolimus Avansor 5 mg Tablett | Shortage | 2026-07-20 | 2026-11-30 | |
| 🇦🇹 AT | Everolimus HCS 5 mg Tabletten | Resolved | 2026-06-17 | — | |
| 🇸🇪 SE | Everolimus Krka 2,5 mg Tablett | Shortage | 2026-03-19 | 2026-09-17 | |
| 🇩🇪 DE | Everolimus-ratiopharm 2,5 mg Tabletten | Shortage | 2025-12-01 | 2026-10-01 | Erhöhte Nachfrage |
| 🇮🇹 IT | EVEROLIMUS MEDAC | Shortage | 2025-09-20 | 2026-08-17 | Elevata richiesta: distribuzione contingentata |
Yes. As of 11 September 2026, availability issues are reported in: Germany, Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-17 to 2026-11-30. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
5 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Everolimus: BASG (Austria), BfArM (Germany), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Everolimus — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/everolimus/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Everolimus availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/everolimus/">Everolimus shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>